Biofil Chemicals

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE829A01014
NSEID: BIOFILCHEM
BSEID: 524396

INR

34.48

0.28 (0.82%)

BSENSE

Dec 05

BSE+NSE Vol: 62

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Checkpoint Trend

Phaarmasia

Murae Organisor

Biofil Chemicals

Godavari Drugs

Lasa Supergeneri

Vista Pharma.

Shelter Pharma

Bacil Pharma

Guj. Inject(Ker)

Dipna Pharmachem

Why is Biofil Chemicals & Pharmaceuticals Ltd ?

Weak Long Term Fundamental Strength with a -24.21% CAGR growth in Operating Profits over the last 5 years

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.66
The company has been able to generate a Return on Equity (avg) of 5.27% signifying low profitability per unit of shareholders funds

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Biofil Chemicals for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Biofil Chemicals

-47.95%

-0.98

49.13%

Sensex

4.37%

0.36

11.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.09%

EBIT Growth (5y)

-24.21%

EBIT to Interest (avg)

0.66

Debt to EBITDA (avg)

0.37

Net Debt to Equity (avg)

-0.02

Sales to Capital Employed (avg)

1.88

Tax Ratio

14.67%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.08%

ROCE (avg)

4.21%

ROE (avg)

5.27%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.61

EV to EBIT

55.32

EV to EBITDA

55.32

EV to Capital Employed

2.64

EV to Sales

1.30

PEG Ratio

0.04

Dividend Yield

ROCE (Latest)

1.05%

ROE (Latest)

13.38%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company

NET SALES(Latest six months)

At Rs 19.97 cr has Grown at 84.06%

PAT(Latest six months)

Higher at Rs 2.49 cr

-3What is not working for the Company

PAT(Q)

At Rs 0.08 cr has Fallen at -88.5% (vs previous 4Q average

Loading Valuation Snapshot...

Here's what is working for Biofil Chemicals

Net Sales - Latest six months

At Rs 19.97 cr has Grown at 84.06%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (Rs Cr)

Here's what is not working for Biofil Chemicals

Profit After Tax (PAT) - Quarterly

At Rs 0.08 cr has Fallen at -88.5% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs 0.70 Cr

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)